Domov › Velika depresivna motnja › Oklahoma
Klinične študije za Velika depresivna motnja v Oklahoma
12 študij za Velika depresivna motnja išče udeležence na lokacijah v Oklahoma.
Mesta v Oklahoma
Uradno besedilo študije (angleško)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Conrad Clinical Research, Edmond
- Sooner Clinical Research, Oklahoma City
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Conrad Clinical Research, Edmond
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06559306A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Sooner Clinical Research, Oklahoma City
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07076407A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Pahl Pharmaceutical Professionals Llc, Oklahoma City
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06775379A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
- Neurocrine Clinical Site, Oklahoma City
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Sooner Clinical Research /ID# 277659, Oklahoma City
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07276997Neural Response to Inflammatory Challenge in Major Depressive Disorder
- Laureate Institute for Brain Research, Tulsa
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 21. apr. 2026 · NCT04751331Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #107, Oklahoma City
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 20. jan. 2026 · NCT06633016Study of ALTO-300 in MDD
- Site 195, Oklahoma City
Vključevanje udeležencevFaza 2
Starost 18–70 · Vsi spoli · Posodobljeno 24. jul. 2025 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 23. jan. 2025 · NCT06223880Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.